ECG Asystole Alarm Validation via Pulse Regularity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing ECG monitoring techniques are prone to high false positive asystole detection events, leading to unnecessary medical responses and potential desensitization, while attempts to reduce these false positives often increase the risk of false negative events, which can result in delayed medical assistance during actual cardiac arrests.
Innovation Solution
A patient monitoring system that combines ECG signal monitoring with a secondary physiological signal, such as arterial blood pressure or plethysmogram, using a pulse regularity index (PRI) to validate asystole alarms, ensuring accurate detection without suppressing true alarms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ECG monitoring alone is used to detect asystole, then detection speed is fast and accuracy is high, but false positive events occur frequently leading to unnecessary medical responses
Solution Approach 1:
The patent introduces a secondary physiological signal (such as arterial blood pressure or plethysmogram) as an intermediary to validate ECG asystole detections. This mediator signal helps distinguish true asystole events from false positives by checking whether the secondary signal also indicates cardiac arrest, thereby reducing false alarm rate while maintaining detection accuracy
Solution Approach 2:
The system implements feedback validation by continuously monitoring the secondary physiological signal and using it to confirm or reject ECG-based asystole alarms. The feedback mechanism compares the secondary signal's pulse characteristics against the ECG detection, allowing real-time verification that reduces false positive events
2Object-generated harmful factors
If validation methods using secondary physiological signals are applied to reduce false positives, then false alarm rate decreases, but the risk of false negative events increases
Solution Approach 1:
The patent changes the validation parameter from simple pulse presence to pulse regularity assessment. By evaluating the regularity of pulse intervals in the secondary physiological signal, the system can more accurately distinguish between true asystole (irregular or absent pulses) and false positives (regular pulses), reducing false negatives while maintaining false positive reduction
3Object-generated harmful factors
If aggressive validation thresholds are used to suppress false alarms, then false positive events are reduced, but true asystole events may be missed
Solution Approach 1:
The system dynamically adjusts validation criteria based on the characteristics of the secondary physiological signal and the clinical context. Rather than using fixed aggressive thresholds, the system adapts its validation sensitivity to maintain optimal balance between suppressing false alarms and detecting true asystole events promptly
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A patient monitor comprises: an electrocardiograph (14, 20) monitoring an electrocardiographic signal (40) of a patient (10); a secondary physiological signal monitor (16, 20) monitoring a second physiological signal (50) of the patient concurrently with the electrocardiograph monitoring the electrocardiographic signal of the patient; an alarm condition detector (42, 44) configured to detect an alarm condition based on the electrocardiographic signal of the patient; an alarm condition validator (52, 54, 56) configured to validate the alarm condition based on pulse regularity of a pulsatile component of the concurrently monitored second physiological signal of the patient; and an alarm indicator (24, 26, 58) configured to generate a human perceptible alarm conditional upon both the alarm condition detector detecting an alarm condition and the alarm condition validator validating the alarm condition.